- Location
ALK
"-
AMSBIO Has Launched CancerSeq
Feb 27, 2014AMSBIO has launched CancerSeq™ - a new range of genetically characterised FFPE tissue samples. CancerSeq™ samples are prepared from genomic DNA extracted from the FFPE tumour tissues and validated by Next Generation ...
-
FDA Allergenic Committee Will Meet to Discuss Bla for Ragweed Sublingual AIT Tablet
Dec 30, 2013Denmark-based pharmaceutical company ALK-Abello has announced that the FDA Allergenic Products Advisory Committee of the US Food and Drug Administration (FDA) will meet on 28 January 2014 to discuss the biologic license application (BLA) ...
-
Pfizer Has Secured Regular Approval From The Us Food and Drug Administration (FDA)
Nov 25, 2013Pfizer has secured regular approval from the US Food and Drug Administration (FDA) for its Xalkori (crizotinib) capsules to treat patients with metastatic ALK-positive non-small cell lung cancer (NSCLC). The approval was based on ...
-
Ignyta Has Entered Into a License Agreement with Nerviano Medical Sciences
Nov 6, 2013US-based biotechnology firm Ignyta has entered into a license agreement with Nerviano Medical Sciences (Nerviano), under which Ignyta will get exclusive global development and marketing rights of tyrosine kinase inhibitors RXDX-101 and ...
Tags: Ignyta, Tyrosine Kinase Inhibitors
-
Loxo Oncology Acquired Rights to This Program From Array Biopharma
Oct 30, 2013US-based Loxo Oncology has announced that its lead clinical program is a potent and selective inhibitor of the Trk family of receptor tyrosine kinases. Loxo Oncology acquired rights to this program from Array Biopharma, which had pursued ...
Tags: Loxo Oncology, Medicine
-
Cell Signaling Technology Has Presented a Specific HER3 Rabbit Monoclonal Antibody
Aug 30, 2013Cell Signaling Technology has presented a specific HER3 rabbit monoclonal antibody (mAb) for researchers studying HER2-mediated breast, lung and ovarian tumors. The company has introduced this product with the recent need for HER3 in HER2 ...
-
PeopleNet Will Be Drilling Deeper Into The U.S. Energy Services Transportation Sector
Aug 26, 2013PeopleNet will be drilling deeper into the U.S. energy services transportation sector, the company announced today at its 11th Annual User Conference in San Antonio, TX. "We're fast-tracking our product expansion by combining PeopleNet ...
Tags: Transportation, Auto Parts
-
FDA Acceptance of Biologics License Application Sublingual Allergy Immunotherapy Tablet
May 13, 2013Merck, referred to as MSD outside the US and Canada, has announced the FDA acceptance of biologics license application (BLA) of investigational ragweed pollen (Ambrosia artemisiifolia) sublingual allergy immunotherapy tablet for review. ...
Tags: Merck Biologics, Medicine
-
The US FDA Has Accepted Merck's BLA for an Investigational AIT
Mar 28, 2013The US FDA has accepted Merck's biologics license application (BLA) for an investigational allergy immunotherapy tablet (AIT), Timothy grass pollen (Phleum pratense). The application includes safety and efficacy data of the ...
Tags: FDA, Merck Bla, Allergy Immunotherapy Tablet
-
Winners Are Named by Nationwide Fur-Free Fashion Contest
Dec 27, 2012The Humane Society of the United States and The Art Institutes announced Nicolle Bajgrowicz, a student in the Bachelor of Fine Arts in Fashion Design program at The Art Institute of California – Orange County, a campus of Argosy ...
Tags: fashion contest, Fashion Design, fur trade, fashion
-
Akzo Nobel Coatings Has Received a Patent for a Coating Composition
Dec 20, 2012Akzo Nobel Coatings has received a patent for a coating composition comprised of a polyacrylate polyol obtained by polymerization of olefinically unsaturated monomers wherein at least 40% weight of the monomers is comprised of linear or ...
-
Clarient Has Entered Into an Agreement for Lung Cancer From Insight Genetics
Dec 18, 2012Clarient Diagnostic Services, a GE Healthcare company, has entered into an agreement to license genomic biomarker for lung cancer from Insight Genetics. AS per the agreement, Clarient intends to develop and assess the performance ...
Tags: Lung Cancer, cooperation, medical technology
-
ALK Has Entered Into an Collaboration Agreement to Supply Pre-Pen to Healthtrust
Dec 18, 2012ALK has entered into an collaboration agreement to supply its FDA approved skin test for the diagnosis of penicillin allergy, PRE-PEN (benzylpenicilloyl polylysine injection USP), to HealthTrust Purchasing Group. Under the agreement, ...
Tags: ALK, collaboration agreement, skin test, penicillin allergy, PRE-PEN
-
European Commission Granted Conditional Marketing Authorization for Pfizer's Xalkori
Dec 6, 2012The European Commission has granted conditional marketing authorization for Pfizer’s Xalkori (crizotinib) to treat anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) in the European Union (EU). ...
Tags: Xalkori, crizotinib, anaplastic lymphoma kinase, ALK
-
Cytocell Unveiled a ROS1 Breakapart FISH Probe Test for Non-Small-Cell Lung Cancer
Dec 5, 2012Cytocell, a developer of fluorescence in situ hybridization (FISH) probes for use in cancer analysis, has unveiled a ROS1 Breakapart FISH probe test for non-small-cell lung cancer (NSCLC). The molecular cytogenetic test, which utilizes ...
Related Products
-
Alkaline Alk Water Electrolysis Electrolyzer for Green Hydrogen Generation and Production
-
Large Scale Alk Electrolyzer Green Hydrogen Generator Via Water Electrolysis
-
Movable Container-Type Alk Pem Hydrogen Generator by Water Electrolysis
-
High Purity 99.9999% Renewable Wind Solar Power Green Hydrogen Generator Via Alk Electrolyzer
-
Factory Price Manufacturer of Alk Electrolytic Cells Hydrogen Water Electrolysis Electrolyzers
-
CE Certified 100% Green Plant Hydrogen / Water Electrolysis/ Pem/Alk Electrolyzer Cell
